Stejbach Mark

Avg. Two Year Performance

41% Avg. Purchase Return
19% Compound
43% Avg. Sale Return
19% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return22%20%42%45%41%
Purchase Success Rate2 of 43 of 43 of 42 of 41 of 4
Average Sale Return9%43%33%27%43%
Sale Success Rate4 of 66 of 66 of 66 of 66 of 6
Health Services » Medical Laboratories & Research

VP and Chief Commercial Offcr:

Holdings: 28.66K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Delivery

SVP/Chief Comm Off, Alks Inc:

Holdings: 51.06K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--